CVE:THCX Hydropothecary (THCX) Stock Forecast, Price & News C$5.30 +0.33 (+6.64%) (As of 06/21/2018) Add Compare Share Share Today's RangeC$5.00▼C$5.3750-Day RangeC$5.30▼C$5.3052-Week RangeC$1.10▼C$5.42Volume5.38 million shsAverage Volume2.35 million shsMarket CapitalizationC$949.11 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsInsider TradesHeadlinesProfileChartCompetitorsInsider TradesHeadlines About Hydropothecary (CVE:THCX) StockThe Hydropothecary Corporation, together with its subsidiaries, produces and distributes medical marijuana products. The company is headquartered in Gatineau, Canada.Read More Receive THCX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Hydropothecary and its competitors with MarketBeat's FREE daily newsletter. Email Address THCX Stock News HeadlinesApril 16, 2023 | finance.yahoo.comAXS CANNABIS ETF ESTIMATED CASH (^THCX-EU)February 25, 2023 | uk.finance.yahoo.comThe Hydropothecary Corporation (HEXO.TO)June 7, 2023 | Edge On The Street (Ad)146 Pounds of Graphite Needed for Each EVGraphite - not lithium - is the largest component of lithium-ion batteries used in electric vehicles. That's why 97 more graphite mines will be needed by 2035 just to keep up with battery demand for the $7 trillion EV market.February 17, 2023 | finance.yahoo.comAXS Cannabis ETF (THCX)August 16, 2022 | prnewswire.comOutlook on the Medical Cannabis Global Market to 2027 - Emergence of Cannabis Legalization Presents Opportunities USA - English - USA - English - PR NewswireAugust 15, 2022 | businesswire.comThe Worldwide Medical Cannabis Industry is Expected to Reach $24.8 Billion by 2027 - ResearchAndMarkets.com - Business WireAugust 3, 2021 | gurufocus.comBedel Financial Consulting, Inc. Buys Innovator S&P 500 Power Buffer ETF - GuruFocus.comAugust 2, 2021 | gurufocus.comOptimum Investment Advisors Bu - GuruFocus.comJune 7, 2023 | Edge On The Street (Ad)The $193 Billion US-China War You Don't Know AboutThey're fighting for control of lithium – a key ingredient in EVs and clean energy technology. It's arguably the most important commodity of the 21st century. China owns 80% of global supply. But the US plans to grab a massive slice of the lithium market, which is forecasted to quadruple to $193 billion by 2028, according to Fortune Business Insights.July 30, 2021 | markets.businessinsider.comThe Week In Cannabis: Tilray's Huge Week, Colin Hanks, Allen Iverson, Seth Rogen And More - Markets InsiderJuly 30, 2021 | gurufocus.comBaldwin Brothers Inc Buys Marr - GuruFocus.comJuly 20, 2021 | finance.yahoo.comCannabis Global Comments on the Publication of its Cannabis Nanotechnology Patent Application - Yahoo FinanceJuly 20, 2021 | stockhouse.comCannabis Global Comments on the Publication of its Cannabis Nanotechnology Patent Application - StockhouseJune 30, 2021 | prnewswire.comHigh Tide Reports Second Quarter 2021 Financial Results Featuring a 99% Increase in Revenue and Another Record Adjusted EBITDA of $4.7 Million - PRNewswireJune 28, 2021 | businesswire.comHigh Tide Reports Second Quarter 2021 Financial Results Featuring a 99% Increase in Revenue and Another Record Adjusted EBITDA of $4.7 Million - Business WireJune 18, 2021 | finance.yahoo.comYour CBD Store Unveils New "BEYOND by SUNMED" Line, Using Innovative Process to Create Unprecedented Fuller Spectrum Experience - Yahoo FinanceMay 4, 2021 | seekingalpha.comPOTX Leaves Investors Dazed And Confused - Seeking AlphaMarch 24, 2021 | prnewswire.comAustralis Completes First Stage in Green Therapeutics LLC Acquisition - PRNewswireMarch 12, 2021 | prnewswire.comAUSTRALIS Completes Definitive Agreement to Acquire Green Therapeutics LLC - PRNewswireFebruary 27, 2021 | yahoo.comKate Hudson remembers wardrobe malfunction at Golden Globes: 'I was sitting, actually, next to Prince' - Yahoo EntertainmentFebruary 16, 2021 | finance.yahoo.comBitcoin pulls back from brink of $50,000 - Yahoo FinanceFebruary 16, 2021 | finance.yahoo.comNicox’s U.S. Licensee Eyevance Expands U.S. Promotion of ZERVIATE® In Agreement with Hikma - Yahoo FinanceFebruary 15, 2021 | finance.yahoo.comCable One to buy telecom firm Hargray Communications in $2.2 bln deal - Yahoo FinanceFebruary 15, 2021 | finance.yahoo.comEbola vaccination campaign begins in Democratic Republic of Congo - Yahoo FinanceFebruary 15, 2021 | finance.yahoo.comChina reports 7 new COVID-19 cases vs 8 a day earlier - Yahoo FinanceFebruary 15, 2021 | finance.yahoo.comGoogle fined $1 million for misleading French hotel rankings - Yahoo FinanceFebruary 15, 2021 | finance.yahoo.comRussia to review effectiveness of its COVID-19 vaccines against new variants - TASS - Yahoo FinanceSee More Headlines THCX Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Industry, Sector and Symbol Stock ExchangeCVE Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolCVE:THCX CUSIPN/A CIKN/A Webwww.thehydropothecary.com Phone+1-416-7504949FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares179,077,000Free FloatN/AMarket CapC$949.11 million OptionableNot Optionable BetaN/A Key ExecutivesMr. Sebastien G. St-Louis (Age 34)Co-Founder, Pres, CEO & Director Mr. Adam Miron (Age 34)Co-founder, Chief Brand Officer & Director Mr. Ed Chaplin (Age 48)CFO & Corp. Sec. Mr. James McMillan (Age 50)VP of Bus. Devel. Mr. Arno GrollDirector of OperationsKey CompetitorsKnight TherapeuticsTSE:GUDCanopy GrowthTSE:WEEDSupreme CannabisTSE:FIREAurora CannabisTSE:ACBESSA PharmaCVE:EPIView All Competitors THCX Stock - Frequently Asked Questions How have THCX shares performed in 2023? Hydropothecary's stock was trading at C$5.30 at the beginning of the year. Since then, THCX shares have increased by 0.0% and is now trading at C$5.30. View the best growth stocks for 2023 here. What other stocks do shareholders of Hydropothecary own? Based on aggregate information from My MarketBeat watchlists, some companies that other Hydropothecary investors own include Aurora Cannabis (ACB), Canopy Growth (WEED), Aphria (APHA), Cronos Group (CRON), CannTrust (CTST), Funko (FNKO), Riot Platforms (RIOT) and Unrivaled Brands (TRTC). What is Hydropothecary's stock symbol? Hydropothecary trades on the Canadian Venture Exchange (CVE) under the ticker symbol "THCX." How do I buy shares of Hydropothecary? Shares of THCX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. What is Hydropothecary's stock price today? One share of THCX stock can currently be purchased for approximately C$5.30. How much money does Hydropothecary make? Hydropothecary (CVE:THCX) has a market capitalization of C$949.11 million. How can I contact Hydropothecary? Hydropothecary's mailing address is 120 Ch de la Rive, GATINEAU, QC J8M 1V2, Canada. The official website for the company is www.thehydropothecary.com. The company can be reached via phone at +1-416-7504949. This page (CVE:THCX) was last updated on 6/7/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Hydropothecary Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.